Mino 人套細(xì)胞淋巴瘤細(xì)胞、返回列表頁(yè)

舉報(bào) 評(píng)價(jià)

參考價(jià)

面議

具體成交價(jià)以合同協(xié)議為準(zhǔn)

產(chǎn)品型號(hào)

品牌

廠商性質(zhì)生產(chǎn)商

所在地

在線詢價(jià) 加入對(duì)比查看聯(lián)系電話

更新時(shí)間：2025-02-11 21:37:56瀏覽次數(shù)：8次

聯(lián)系我時(shí)，請(qǐng)告知來自化工儀器網(wǎng)

同類優(yōu)質(zhì)產(chǎn)品更多>

產(chǎn)品分類品牌分類

細(xì)胞庫(kù) / 細(xì)胞培養(yǎng): 細(xì)胞株 ATCC細(xì)胞原代細(xì)胞干細(xì)胞普通細(xì)胞

全部產(chǎn)品列表

產(chǎn)品簡(jiǎn)介

Mino人套細(xì)胞淋巴瘤CatalogueNo

詳情介紹

Mino 人套細(xì)胞淋巴瘤
Catalogue No.: C462
Product Format: a 15 ml centrifuge tube
Culture Properties：懸浮
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

Item	Specifications
a 15 ml centrifuge tube	2X10⁶
Manual	1 copy

Caucasians (2). The rarity of T-NEN has resulted in a lack of large series and clinical trials, so there are limited guidelines or consensus statements for optimal treatment. Surgical resection is widely agreed to be the only curative method for resectable T-NEN, while chemotherapy with or without radiotherapy is recommended for patients with unresectable or metastatic disease (3). Nevertheless, the long-term outcome of patients with metastatic